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1 Abstract 	  
Within this thesis, strain characteristics and antibiotic resistance profiles of the two 
main udder pathogens S. aureus and E. coli are provided and a new PCR based 
identification system for A. pluranimalium is described. 
A total of 78 S. aureus strains were further characterized. In the Staphaurex test, 
49% of the isolates were latex-positive and 51% latex-negative. All latex-negative 
strains were assigned to CC151, whereas latex-positive strains were assigned to 
various clonal complexes. While the latex-negative isolates were susceptible to all 
antimicrobial agents tested, 13 % of latex-positive isolates were resistant to both 
ampicillin and penicillin. Microarray profiles of latex-negative isolates were highly 
similar, but differed largely from those of latex-positive isolates. Our findings suggest 
latex-negative isolates to represent a group of closely related strains with specific 
resistance and virulence gene patterns. 
Eighty-three E. coli strains were tested for their sensitivity to various antibiotics and 
genotyped by pulsed field gel electrophoresis (PFGE). 16.9 % of the isolates were 
resistant to one or more antimicrobial agents and 10.8 % were multiresistant. 
Amoxicillin-clavulanic acid, gentamicin and third generation cephalosporins proved 
effective against the majority of these strains. Nevertheless, one blaCTX-M-14 
harbouring ESLB-producing strain was found. Genotyping demonstrated that E. coli 
from cows with mastitis were very diverse. 
To identify A. pluranimalium, primers (PlaF/PlaR) based on the pluranimaliumlysin 
(pla) gene were designed and evaluated. The primer pairs revealed a correctly sized 
amplification product (458 bp) with all target strains tested, whereas no amplification 
product was obtained for all non-target strains.  
 
Key words: bovine mastitis, antibiotic resistance, genotyping, main udder pathogens, 
A. pluranimalium 	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Zusammenfassung 
 
In dieser Arbeit werden Stamm-Eigenschaften der zwei häufigsten Mastitis-Erreger 
S. aureus und E. coli besprochen. Zudem wird ein neues PCR basiertes 
Identifikationssystem für A. pluranimalium beschrieben. 
78 S. aureus-Stämme wurden weitergehend charakterisiert. Im Staphaurex Test 
waren 51% aller Isolate negativ. Alle Test-negativen Stämme gehörten zum CC151 
während die Test-positiven Stämme verschiedenen CC zugeordnet wurden. Die 
Test-negativen Isolate waren empfindlich gegen alle getesteten Antibiotika, jedoch 
zeigten 13% der Test-positiven Isolate Resistenz gegen Ampicillin und Penizillin. Die 
Microarray-Profile der Test-negativen Isolate waren sich sehr ähnlich aber 
unterschieden sich deutlich von denen der Test-positiven. 
83 E. coli-Stämme wurden auf ihre Empfindlichkeit gegen verschiedene Antibiotika 
getestet und mittels PFGE genotypisiert. 16.9% aller Isolate waren resistent gegen 
eines oder mehrere Antibiotika und 10.8% waren multiresistent. Amoxicillin-
Clavulansäure, Gentamicin und Cephalosporine der 3. Generation erwiesen sich als 
wirksam gegen die Mehrheit der Stämme. Die Genotypisierung zeigte, dass E. coli-
Stämme isoliert von Kühen mit Mastitis sehr unterschiedlich sind. 
Zur Identifizierung von A. pluranimalium wurden Primer basierend auf dem 
Pluranimaliumlysin-Gen designt und evaluiert. Das Primer-Paar führte bei allen 
Zielstämmen zu einem Amplikon der richtigen Größe (458bp) während bei den Nicht-
Zielstämmen kein Amplikon generiert wurde. 
 
Schlüsselwörter: bovine Mastitis, Antibiotikaresistenzen, Genotypisierung, häufigste 
Mastitiserreger, A. pluranimalium 
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2.1 Interpretive Summary 	  
More than 50% of Staphylococcus (S.) aureus strains causing bovine mastitis are 
latex test negative in the Staphaureux latex agglutination test. Our study associated 
the latex agglutination phenotype of 78 S. aureus bovine mastitis isolates from 57 
Swiss farms with genomic and antibiotic resistance features. We identified major 
differences between latex test positive and latex test negative strains with regard to 
antibiotic resistance, virulence gene profiles, and the assigned clonal complexes. The 
generated data provides new insights into genomic features of latex test positive and 
latex test negative strains. It also contributes to the identification of potential vaccine 
targets. 
 
 
 
2.2 Abstract 	  
The dairy industry suffers from massive economic losses due to staphylococcal 
mastitis in cattle. Staphaureux latex agglutination test was reported to lead to 
negative results in 54% of bovine Staphylococcus aureus strains and latex-negative 
strains were hypothesized to be less virulent than Staphaurex test positive strains. 
However, comparative information on virulence and resistance profiles of these two 
groups of S. aureus is scarce. Our objective was to associate the latex agglutination 
phenotype of S. aureus strains isolated from bovine mastitis milk with data on clonal 
complexes, virulence genes, and antibiotic resistance in order to 1) determine the 
virulence profiles of the Staphaureux test positive and Staphaurex test negative 
groups, and 2) provide data needed to improve treatment of bovine mastitis and to 
identify potential vaccine targets. A total of 78 S. aureus strains isolated from 78 
different cows at 57 Swiss farms were characterized. Latex agglutination was tested 
by Staphaureux kit and resistance profiles were generated by disk diffusion. DNA 
microarray was used to assign clonal complexes and to determine virulence and 
resistance gene profiles. In the Staphaureux test, 49% of the isolates were latex-
positive and 51% latex-negative. All latex-negative strains were assigned to CC151, 
whereas latex-positive strains were assigned to various clonal complexes including 
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CC97 (n = 16), CC8 (n = 10), CC479 (n = 5), CC20 (n = 4), CC7 (n = 1), CC9 (n = 1) 
and CC45 (n = 1). While the latex-negative isolates were susceptible to all 
antimicrobial agents tested, 24% of latex-positive isolates were classified 
intermediate with regard to cefalexin-kanamycin and 13 % were resistant to both 
ampicillin and penicillin. Microarray profiles of latex-negative isolates were highly 
similar, but differed largely from those of latex-positive isolates. While the latex-
negative group lacked several enterotoxin genes and sak, it exhibited significantly 
higher prevalence rates of genes encoding enterotoxin C, toxic shock syndrome 
toxin, and leukocidins (lukM/lukF-P83, lukD). Our findings suggest latex negative 
isolates to represent a group of closely related strains with specific resistance and 
virulence gene patterns. 
 
 
Key words: Staphylococcus aureus, bovine mastitis, latex agglutination, virulence 
 
 
 
2.3 Introduction 
 
The dairy industry suffers from massive economic losses due to staphylococcal 
mastitis in cattle (Wells et al., 1998). The Staphaurex latex agglutination test 
represents a diagnostic instrument widely used to confirm putative Staphylococcus 
(S.) aureus isolates through detection of characteristic S. aureus surface proteins. 
Latex particles coated with human IgG and fibrinogen interact with the bacterial 
target proteins SpA (staphylococcal protein A), ClfA/B (clumping factor A/B), and 
FnbA/B (fibronectin-binding protein A/B), mediating a rapid agglutination reaction 
visible to the naked eye. While the Staphaurex latex agglutination test exhibits high 
specificity (99.5%) and sensitivity (99.8%) when applied to S. aureus strains obtained 
from humans, Stutz et al. (Stutz et al., 2011) reported that 54% of S. aureus isolates 
obtained from cases of bovine mastitis yield negative test results. These false-
negative results are due to sequence polymorphisms leading to impaired functionality 
of one or several of the targeted virulence factors SpA, ClfA/B, and FnbA/B. 
Therefore, Staphaurex latex agglutination test negative (SLAT(-)) strains have been 
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hypothesized to be less virulent than Staphaurex latex agglutination test positive 
(SLAT(+)) strains (Stutz et al., 2011). Although the assessment of the virulence 
potential of SLAT(-) strains is of crucial importance to the dairy industry, data on the 
genomic background and antimicrobial resistance of bovine SLAT(-) isolates is 
scarce.  
Though antibiotic treatment is widely used to fight bovine mastitis, its merits are 
controversially discussed. Use of antimicrobial agents is not only economically 
questionable and favors the development of antibiotic resistance, but it is also 
unsuitable to address the issue of intracellular persistance of the organism (Fluit, 
2012; Saini et al., 2012; Steeneveld et al., 2011). Therefore, increased efforts are 
now focused on the development of vaccines. Recent studies postulate extended 
characterization of the genetic background of bovine mastitis isolates to enable 
identification of proteins crucial for colonization and infection that could serve as 
biomarkers in the identification of vaccine targets (Fluit, 2012; Klein et al., 2012).  
The objective of this study is to link the latex agglutination phenotype of S. aureus 
strains isolated from bovine mastitis milk with data on clonal complexes, virulence 
genes and antibiotic resistance in order to 1) determine the virulence profiles of the 
SLAT(+) and SLAT(-) groups, and 2) provide data needed to improve treatment of 
bovine mastitis and to identify potential vaccine targets. 
 
 
 
2.4 Materials and Methods 	  
2.4.1 Bacterial isolates, DNA extraction and presumptive species identification 	  
A total of 78 S. aureus strains was isolated from bovine mastitis milk samples 
collected from different cows at 57 Swiss farms between March 2011 and Feb 2012. 
Putative S. aureus isolates were identified by streaking samples onto rabbit plasma 
fibrinogen plates (Oxoid, Basel, Switzerland), which were subsequently incubated at 
37°C and examined for coagulase activity after 48 h. A single S. aureus typical 
colony of each plate was transferred to blood agar and incubated over night at 37°C. 
DNA isolation kits were supplied by QIAGEN (Hilden, Germany) and handled 
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according to the manufacturer’s instructions. The concentration of nucleic acids was 
measured using Nanodrop ND-1000 UV/Vis spectrophotometer (NanoDrop 
Technologies, Wilmington, DE). 
 
 
2.4.2 Staphaurex Latex Agglutination Test 
 
Staphaurex test kit (Oxoid, Basel, Switzerland) was used according to the 
manufacturer’s instructions to determine latex agglutination. 
 
 
2.4.3 Genotyping using DNA microarray 	  
Presence of 284 genes and allelic variants was assessed using StaphyType 
ArrayStrips (Clondiag chip technologies, Jena, Germany) following the 
manufacturer’s instructions. Multiplex linear DNA amplification and microarray 
hybridization allowed for identification of markers, genes conferring resistance to 
antimicrobial agents, and virulence determinants such as genes encoding 
enterotoxins, toxic shock syndrome toxin, leukocidins, hemolysins, and adhesins. 
The microarray also enables assignment of strains to clonal complexes and agr 
types. DNA microarray profiles were converted to sequence-like strings as described 
elsewhere to allow for visualization by SplitsTree4, a software package designed to 
compute unrooted phylogenetic networks from molecular sequence data (Huson et 
al., 2006; Wattinger et al., 2012). 
 
 
2.4.4 Susceptibility testing 	  
Disk diffusion was used to classify isolates as susceptible, intermediate or resistant 
depending on respective zone diameters following CLSI standard protocols (Clinical 
and Laboratory Standards Institute, 2008). All antimicrobial agents were chosen with 
regard to their relevance in mastitis therapy. Antibiotic agents tested included 
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ampicillin (30 µg), amoxicillin (20 µg) with clavulanic acid (10 µg), cephalothin (30 
µg), ceftiofur (30 µg), erythromycin (15 µg), cefoxitin (30 µg), gentamicin 10 (µg), 
kanamycin (30 µg), kanamycin-cefalexin (30 µg/ 15 µg), penicillin (10 U.I.), and 
penicillin-novobiocin (10 U.I/ 30 µg). Mueller-Hinton agar, as well as disks containing 
ceftiofur and penicillin-novobiocin were provided by Oxoid, while disks containing 
cefalexin-kanamycin (Ubrolexin®) were provided by Boehringer Ingelheim (Basel, 
Switzerland). All other disks containing antibiotic agents were obtained from Becton 
Dickinson (Basel, Switzerland). Reference strain S. aureus ATCC 25923 was used 
as a quality control. 
 
 
2.4.5 Statistical analysis 	  
The distribution of specific genes among latex-positive and latex-negative isolates 
was compared based on the hybridization results of the DNA microarray. SPSS 
Statistics 19 (SPSS Inc., Chicago, IL) was used to run Pearson’s chi-squared test, 
identifying significant associations between the latex-phenotype and the presence of 
the examined genes. Results were considered to be statistically significant for p-
values < 0.050. 
 
 
 
2.5 Results 	  
2.5.1 Species confirmation and exclusion criteria 	  
All isolates were confirmed to represent S. aureus using the species markers of the 
DNA microarray. To avoid bias, the sample collection was screened for identical 
isolates by comparison of all features tested including microarray profiles and 
resistance patterns, and all isolates were found to be unique. 
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2.5.2 Latex agglutination and clonal complexes 	  
Latex agglutination was tested for all 78 confirmed bovine S. aureus strains. While 38 
isolates (49%) were latex-positive and would have been correctly identified as S. 
aureus, 40 isolates (51%) were latex-negative (false-negative). As depicted in the 
Splitstree in Figure 1, all latex-negative strains exhibit very similar resistance and 
virulence gene profiles. They form a single cluster of isolates assigned to CC151, 
while latex-positive strains were assigned to various clonal complexes including 
CC97 (n = 16), CC8 (n = 10), CC479 (n = 5), CC20 (n = 4), CC7 (n = 1), CC9 (n = 1), 
and CC45 (n = 1). 
 
 
2.5.3 Resistance phenotypes (disk diffusion) 	  
Resistance phenotypes determined by disk diffusion are listed in Table 1. The 
SLAT(-) isolates were susceptible to all antimicrobial agents tested. Among the 
SLAT(+) group, 24% of the isolates were classified intermediate with regard to 
cefalexin-kanamycin and 13% of isolates were classified resistant to both ampicillin 
and penicillin. No MRSA (methicillin resistant S. aureus) isolates were detected 
among the bovine mastitis strains investigated in this study. 
 
 
2.5.4 Resistance and virulence gene profiles 	  
Selected DNA microarray results on resistance and virulence genes are depicted in 
Table 2. While no resistance genes were detected among SLAT(-) isolates, some 
SLAT(+) isolates exhibited genes involved in resistance to antibiotic agents including 
blaI/R/Z (26%), ermC (3%), fosB (39%), and vanB (3%). Several SLAT(+) strains 
also displayed enterotoxin genes entA (21%), entD (26%), and entJ (16%), as well as 
sak encoding staphylokinase (26%), virulence factors that were not found among 
SLAT(-) isolates. In contrast, the SLAT(-) group exhibited significantly higher 
prevalence rates of both tested allelic variants of entC, as well as the egc enterotoxin 
gene cluster, genes encoding toxic shock syndrome toxin, and leukocidins lukM/lukF-
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P83 and lukD. Neither pvl, encoding panton-valentine leukocidin, nor etA/B/C, 
encoding exfoliative toxins, were detected in this study. Microarray data on the 
presence of selected adhesin genes coding for target proteins of the Staphaureux 
test is presented in Table 2. While almost all strains were positive for one or more 
allelic variants of the adhesin genes tested, latex-positive and latex-negative isolates 
differ largely in the allelic variants found. A comprehensive overview of the 
prevalence rates of all genes tested is provided as a supplemental file that also 
comprises p-values used to determine significant differences in the prevalence of 
respective genes among SLAT(+) and SLAT(-) isolates. 
 
 
 
2.6 Discussion 	  
While Staphaureux test kit exhibits high specificity (99.5%) and sensitivity (99.8%) 
when applied to S. aureus strains obtained from humans, it frequently leads to false-
negative results when applied to S. aureus isolates obtained from bovine mastitis 
milk. We detected 51% SLAT(-) isolates, consistent with the rate of 54% reported by 
Stutz et al. (Stutz et al., 2011). In both studies SLAT(+) isolates were associated with 
a wide range of clonal complexes, whereas the SLAT(-) isolates were assigned to 
CC151 only. CC151 was reported to represent the most prevalent clonal complex 
among S. aureus isolated from bovine milk obtained from both seemingly healthy, as 
well as clinically infected udders (Sakwinska et al., 2011; Schlotter et al., 2012; Stutz 
et al., 2011). The most frequent clonal complexes among SLAT(+) strains in our 
study included CC97, CC8, CC497, and CC20, while CC7, CC9, and CC45 were 
assigned to only one isolate each. Interestingly, no isolates were assigned to CC133, 
a dominant clonal complex among S. aureus isolated from the milk of seemingly 
healthy cows in Germany (Schlotter et al., 2012).  
When antimicrobial susceptibility was determined, the resistance proportions among 
clonal complexes differed, with CC151, CC479, and CC20 representing the only 
clonal complexes that comprised no resistant isolates. These findings are consistent 
with an extensive study on antimicrobial resistance among Swiss and French bovine 
S. aureus isolates, in which penicillin resistance rates among CC151 and CC20 were 
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found to be far lower than those among CC97 (Sakwinska et al., 2011). Overall, a 
total of 6% of bovine S. aureus isolates tested in our study were resistant to both 
ampicillin and penicillin, and 12% exhibited intermediate susceptibility to 
kanamycin/cefalexin. While the emergence of livestock-associated MRSA represents 
an increasing problem in Switzerland (Huber et al., 2010) and worldwide, no MRSA 
isolates were detected among the mastitis isolates investigated in our study. The 
single strain exhibiting vanB, one of the genes involved in vancomycin resistance, 
was found to be sensitive to vancomycin by Etest. 
DNA microarray results indicate that the resistance and virulence gene profiles of the 
SLAT(-) strains in our study are highly similar, but differ largely from those of SLAT(+) 
strains (see Splitstree, Figure 1). Epidemiological studies suggest that a subset of S. 
aureus strains exhibits a distinctive genetic background that renders them highly 
successful in causing bovine mastitis (Herron-Olson et al., 2007). The SLAT(-) 
isolates characterized in our study lack several virulence genes frequently found 
among SLAT(+) isolates, including genes coding for resistance factors, 
staphylokinase, and enterotoxins A, D, and J. This particular combination of 
enterotoxin genes entA, entD, and entJ was recently described to represent one of 
the main criteria in the identification of S. aureus strains classified as genotype B 
(Boss et al., 2011). Strains of this genotype were reported to be exclusively 
associated with very high (up to 65%) within-herd prevalence of mastitis (Graber et 
al., 2009). In our study, strains exhibiting the combination of entA, entD, and entJ 
were assigned to CC8 only. A wide variety of enterotoxin genes can be found among 
S. aureus isolates obtained from cases of bovine mastitis (Monecke et al., 2007). 
Still, the exact role of enterotoxins in the pathogenesis of bovine mastitis remains 
poorly understood (Haveri et al., 2007).  
Among SLAT(-) strains, we found significantly higher numbers of several other 
virulence genes, including genes coding for toxic shock syndrome toxins (tst-1, tst-
RF122), enterotoxins (entC, egc-cluster), and leukocidins (lukM/lukF-P83, lukD). 
Recent studies suggest lukM/lukF-P83 to play a role in the pathogenesis of bovine 
mastitis (Barrio et al., 2006; Schlotter et al., 2012).  
As false-negative results in the Staphaurex test are due to impaired functionality of 
one or several of the targeted virulence factors SpA, ClfA/B, and FnbA/B, SLAT(-) 
strains have been hypothesized to be less virulent than SLAT(+) strains (Stutz et al., 
2011). The DNA microarray results revealed considerable heterogeneity regarding 
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clfA/B and FnbA/B, and we found SLAT(-) and SLAT(+) isolates to exhibit different 
alleles of the respective genes. ClfA/B and FnbA/B are representatives of the group 
of bacterial surface proteins designated MSCRAMMSs (microbial surface 
components recognizing adhesive matrix molecules). These proteins are of particular 
interest in the development of vaccines, as they mediate adherence of S. aureus to 
components of the host’s extracellular matrix. Attachment of the organism to the 
epithelial cells of the udder, as well as subsequent invasion of epithelial and 
endothelial cells was shown to depend on MSCRAMMs (Lammers et al., 1999; Sinha 
et al., 1999), which also play a role in the evasion of host immune response (Higgins 
et al., 2006). 
 
 
 
2.7 Conclusions 	  
The genomic background of SLAT(-) and SLAT(+) strains differs significantly, 
including a vast range of genes encoding crucial virulence and resistance factors. In 
consideration of the high heterogenity among MSCRAMM genes detected by DNA 
microarray, we conclude that a combination of diverse antigens is crucial to the 
development of highly functional adhesin-based diagnostic tools and vaccines. 
Based on the comparison of microarray profiles and resistance phenotypes of 
SLAT(+) and SLAT(-) bovine mastitis isolates investigated in this study, we 
hypothesize that SLAT(+) strains exceed SLAT(-) strains in virulence potential. 
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2.10 Tables 	  
Table 1: Antimicrobial resistance phenotypes determined by disk diffusion among 
Staphaurex latex agglutination test positive (SLAT(+)) and Staphaurex latex 
agglutination test negative (SLAT(-)) isolates 
 
 Antimicrobial agents1 
 AM AMC CF EFT ERY FOX GM K K/CFX P P/NB 
SLAT(-)            
CC151 (n = 40) 0 0 0 0 0 0 0 0 0 0 0 
            
SLAT(+)            
CC7 (n = 1) 1 0 0 0 0 0 0 0 0 1 0 
CC8 (n = 10) 1 0 0 0 0 0 0 0 (1)2 1 0 
CC9 (n = 1) 1 0 0 0 0 0 0 0 (1)2 1 0 
CC20 (n = 4) 0 0 0 0 0 0 0 0 (3)2 0 0 
CC45 (n = 1) 1 0 0 0 0 0 0 0 0 1 0 
CC97 (n = 16) 1 0 0 0 0 0 0 0 (4)2 1 0 
CC479 (n = 5) 0 0 0 0 0 0 0 0 0 0 0 
            
Total (n = 78) 5 0 0 0 0 0 0 0 (9)2 5 0 
 
1) Abbreviations: AM = ampicillin, AMC = amoxicillin with clavulanic acid, CF = cephalothin, EFT = 
ceftiofur, ERY = erythromycin, FOX = cefoxitin, GM = gentamicin, K = kanamycin, K/CFX = 
kanamycin-cefalexin, P = penicillin, P/NB = penicillin-novobiocin 
2) The number of isolates that exhibited intermediate sensitivity to the respective antimicrobial agent is 
presented in brackets. 
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Table 2: Prevalence of selected virulence and resistance genes detected by DNA 
microarray among Staphaurex latex agglutination test (SLAT(+)) and Staphaurex 
latex agglutination test negative (SLAT(-)) bovine mastitis isolates 
 
Group Gene/Probe Function 
SLAT(+) 
(n = 38) 
SLAT(-) 
(n = 40) 
agr typing agrI accessory gene regulator, type I 84% 0%* 
 agrII  accessory gene regulator, type II  16% 100%* 
Capsule  capsule-5  capsule type 5  79% 0%* 
 capsule-8  capsule type 8 21% 100%* 
Resistance  blaI, blaR, blaZ  beta lactamase resistance 26% 0%* 
 fosB  
putative marker for fosfomycin, 
bleomycin 
39% 0%* 
Enterotoxins  entA  enterotoxin A  21% 0%* 
 entC  enterotoxin C 3% 28%* 
 entCM14  enterotoxin-like protein 3% 100%* 
 entD  enterotoxin D 26% 0%* 
 entJ enterotoxin J 16% 0%* 
 egc-cluster  enterotoxin gene cluster 29% 100%* 
Toxic shock  tst-1 toxic shock syndrome toxin 0% 13%* 
 tst-RF122  
allelic variant of toxic shock 
syndrome toxin from RF122 
0% 15%* 
Leukocidins  lukM/lukF-P83  bovine leukocidin 42% 100%* 
 lukD  leukocidin D component 87% 100%* 
Staphylokinase sak  staphylokinase 26% 0%* 
Spa  spa  staphylococcal protein A 100% 100% 
ClfA/B clfA-all  clumping factor A (ClfA)  97.4% 100% 
 
clfA-
COL+RF122  
ClfA, allele from COL/ RF122  71% 100%* 
 
clfB-
COL+Mu50  
ClfB, allele from COL/ Mu50 26% 0%* 
 clfB-MW2  ClfB, allele from MW2 5% 100%* 
 clfB-RF122  ClfB, allele from RF122 18% 100%* 
FnbA/B  fnbA 
fibronectin-binding protein A 
(FnbA) 
89% 100%* 
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 fnbA-COL  FnbA, allele from COL 29% 0%* 
 
fnbA-
MRSA252 
FnbA, allele from  16% 0%* 
 fnbA-RF122  FnbA, allele from RF122 0% 100%* 
 
fnbB-COL+ 
Mu50+MW2 
fibronectin-binding protein B 
(FnbB) 
100% 0%* 
 
 
*The prevalence of the respective gene differs significantly between the SLAT(+) and SLAT(-
) bovine S. aureus isolates tested in this study (p <0.050). 
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2.11 Figures 	  
Figure 1: Splitstree depicting similarity of resistance and virulence gene profiles 
among SLAT(+) and SLAT(-) bovine mastitis isolates. CC151 represents the only 
cluster comprised of SLAT(-) isolates. The latex phenotype of all isolates clustered in 
one clonal complex is indicated in brackets. 
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3.1 Abstract 	  
Between March 2011 and February 2012 83 E. coli strains were isolated from 
mastitis milk samples from 83 different animals (67 farms) and tested for their 
sensitivity to various antibiotics by means of disk diffusion method and genotyped by 
determination of the phylogenetic groups as well as by pulsed field gel 
electrophoresis (PFGE). The antibiotics were chosen on the basis of their licenses for 
intramammary application in Switzerland. As many as 16.9 % of the isolates were 
resistant to one or more antimicrobial agents. Amoxicillin-clavulanic acid, gentamicin 
and third generation cephalosporins proved effective against the majority of these 
strains. Nevertheless, one blaCTX-M-14 harbouring extended-spectrum-beta-lactamase 
producing strain was found.  Genetic analysis grouped most of the strains (87%) into 
phylogenetic groups A and B1. PFGE genotyping demonstrated that E. coli from 
cows with mastitis even from the same farm were genotypically very diverse. 
 
Keywords: E. coli, mastitis, resistance, genotyping, phylogenetic group, PFGE 
 
 
 
Resistenzprofile und genetische Vielfalt von Escherichia coli Stämmen isoliert 
aus akuten bovinen Mastitiden 
 
Zwischen März 2011 und Februar 2012 wurden 83 E. coli Stämme von 83 
verschiedenen Kühen aus 67 Betrieben gesammelt und auf ihre Empfindlichkeit 
gegenüber verschiedenen Antibiotika getestet. Die Antibiotika wurden aufgrund der 
Zulassung für eine intramammäre Applikation in der Schweiz ausgesucht und die 
Empfindlichkeitstestung mittels Agardiffusions-Methode durchgeführt. Zudem wurden 
alle Stämme hinsichtlich ihrer Zugehörigkeit zu den phylogenetischen Gruppen wie 
auch mittels Pulsfeldgelelektrophorese (PFGE) genotypisiert. 16.9% aller Stämme 
zeigten Resistenzen gegenüber einem oder mehreren Antibiotika. Amoxicillin-
Clavulansäure, Gentamicin und Cephalosporine der dritten Generation erwiesen sind 
als wirksam gegen die Mehrheit der E. coli Stämme. Jedoch wurde ein extended-
Spectrum-beta-Lactamase Bildner, welcher das blaCTX-M-14-Gen trägt, gefunden. Die 
genetische Analyse gruppierte das Gros der Stämme (87%) in die phylogentischen 
 22 
Guppen A und B1. Die weitere Genotypisierung mittels PFGE zeigte eine grosse 
Diversität unter den E. coli Stämmen, auch wenn diese vom selben Betrieb 
stammten. 
 
Schlüsselwörter: E. coli, Mastitis, Resistenz, Genotypisierung, phylogenetische 
Gruppen, PFGE 
 
 
 
3.2 Introduction 	  
Mastitis remains a major challenge to the worldwide dairy industry. For Switzerland, 
the average annual cost due to clinical mastitis has been estimated to be about SF 
300.- per cow (Rüsch, 1995). Escherichia coli is the most common Gram-negative 
bacterium causing acute mastitis in cows worldwide (Hogan and Smith, 2003, 
Ericsson Unnerstad et al., 2009). E. coli induced mastitis is characterized as a 
relatively short-term disease process and induces a distinct acute phase response. 
Antimicrobial treatment of an acute clinical mastitis has to start before the results of 
antimicrobial susceptibility testing are available because of the very often peracute 
course of the disease. Knowledge on current resistance patterns guides this 
"empiric" treatment and will enable a more accurate use of antibiotics. The latest 
published data on resistance profiles of E. coli causing mastitis in cows in 
Switzerland are about 10 years old (Stephan and Rüsch, 1997; Corti et al., 2003). In 
the meantime extended spectrum β-lactamases (ESBL) producing E. coli isolated 
from milk of cows with clinical mastitis were described (Locatelli et al., 2009). And 
recently, a CMY-2 β-lactamase producing E. coli (plasmid-mediated AmpC-producing 
E. coli) isolated from a cow with recurrent mastitis, was found in Switzerland 
(Endimiani et al., 2012). Therefore, from a clinical perspective, current data about 
resistances profiles of E. coli are required.  
The E. coli species encompasses both pathogenic and non-pathogenic strains. 
Pathogenic strains cause a variety of enteric and extraintestinal infections in humans 
and animals, mostly in a host- or organ-specific way. Nevertheless, with regard to 
bovine mastitis, an E. coli pathogenic subset has not been identified yet. Bovine 
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mastitis E. coli do not belong to specific antigen O serogroups (Wenz et al., 2006) 
and are not biochemically different from fecal E. coli  (Nemeth et al., 1994). Because 
of this apparent lack of specific features, it has been largely accepted that there is no 
strain specificity in E. coli bovine mastitis and that various E. coli strains found in the 
environment bear the same potential to cause the disease (Burvenich et al., 2003, 
Fernandes et al. 2011). The aim of this study was to retrieve current data on 
resistance profiles of E. coli strains form bovine mastitis milk samples as well as on 
the degree of genetic variability among isolates in Switzerland.  
 
 
 
3.3 Material and Methods 	  
3.3.1 Strains 	  
A total of 83 E. coli strains from acute clinical cases of bovine mastitis were isolated 
from 83 different animals (67 different farms distributed in the cantons of Zurich, 
Graubünden, Thurgau, Aargau, St. Gallen, Uri and Zug). Not more than two cows per 
farm were included. The isolates were collected between March 2011 and February 
2012. Milk samples were taken during farm calls by the attending veterinarian from 
the affected quarter of each cow in an aseptical manner.  
Using a sterile loop, the samples were streaked onto sheep blood agar base 
(Beckton Dickinson AG, Allschwil, Switzerland), supplemented with 5 % sheep blood 
(Oxoid, Pratteln, Switzerland) as well as onto BROLACIN-Agar (VWR International 
AG, Dietikon, Switzerland) and incubated at 37 °C overnight. The E. coli strains were 
confirmed by colony morphology, Gram stain, and biochemical tests such as acid 
production from mannit, ONPG test, tests for urease, indol and H2S production and 
the lysindecarboxylase test. The strains were stored at -80°C. 
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3.3.2 Susceptibility testing 	  
The strains were subjected to antimicrobial susceptibility testing using the standard 
disk diffusion test according to the protocols recommended by the Clinical and 
Laboratory Standards Institute (2008). The antimicrobial agents tested as well as the 
corresponding interpretative criteria are summarized in Table 1. Bacteria were grown 
4 – 5 h in BHI (Brain Heart Infusion, Oxoid, Pratteln, Switzerland) and diluted to 0.5 
Mac Farland turbidity by comparison with a standard. Thereafter, bacterial 
suspensions were swabbed uniformly across a Müller-Hinton-Agar (Oxoid, Pratteln, 
Switzerland) plate and the filter-paper disks impregnated with the antimicrobial were 
placed on the surface of the agar using a dispenser. The disks were provided from 
Beckton Dickinson AG, Allschwil, Switzerland, except Ceftiofur, which was provided 
from Oxoid, Pratteln, Switzerland. Plates were incubated at 35 °C for 18 h and the 
zone of inhibition (in mm) was assessed and measured using a calliper. Interpretive 
criteria according to the performance standards for antimicrobial disk and dilution 
susceptibility tests for bacteria isolated from animals (Clinical and Laboratory 
Standards Institute, 2008) were used. Accuracy of the test system was monitored by 
including the reference strain E. coli ATCC 25922. 
Additionally the strains were cultured on Brilliance ESBL agar (Oxoid, Pratteln, 
Switzerland) and incubated for 24h at 37°C. Strains, which were able to produce blue 
colonies, were confirmed as ESBL producers on Muller-Hinton agar plates using E-
Test-ESBL strips containing cefotaxime, cefepime or ceftazidime each alone and in 
combination with clavulanic acid (bioMérieux, Marcy l’Etoile, France) according to the 
manufacturer’s recommendations. 
 
 
3.3.3 Identification and sequencing of blaESBL genes 	  
Bacterial strains confirmed for producing ESBLs were further analysed by PCR and 
by sequencing the whole open reading frames (ORF) of bla genes. DNA was 
extracted by a standard heat lysis protocol. Thereafter, specific primer sets were 
used to search for b-lactamase-encoding genes belonging to blaTEM, blaSHV and 
blaCTX-M families (Geser et al., 2011; Geser et al. 2012). Resulting amplicons were 
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purified using the PCR Purification Kit (QIAGEN, Courtaboeuf, France) according to 
the manufacturer’s recommendations. Custom-sequencing was performed by 
Microsynth (Balgach, Switzerland) and the nucleotide and protein sequences were 
analyzed with Codon Code Aligner V. 3.7.1.1. For database searches the BLASTN 
program of NCBI (http://www.ncbi.nlm.nih.gov/blast/) was used. 
 
 
3.3.4 Determination of the E. coli phylogenetic groups 	  
Phylogenetic analyses have shown that E. coli strains fall into four main phylogenetic 
groups (A, B1, B2, D). All isolates in the collection were assigned to phylogenetic 
groups, in which group A/B1 typically contained commensal isolates and group B2/D 
isolates were associated with virulence, using a triplex PCR protocol (Clermont et al., 
2000) after DNA extraction by a standard heat lysis protocol. 
 
 
3.3.5 PFGE 	  
Genetic variability of isolates was determined by macrorestricion analysis and pulsed 
field gel electrophoresis (PFGE) according to the PulseNet standardized protocol for 
the subtyping of E. coli O157, Salmonella, Shigella (Ribot et al., 2006). After 
electrophoresis the gels were ethidium bromide stained and the banding pattern was 
photographed under (UV) illumination and a digital image (that was converted to 
TIFF format) of the pattern was acquired using the GelDoc system (Bio-Rad). The 
TIFF images were analysed using the BioNumerics software GelCompare (Applied 
Maths, Sint-Martens-Latem, Belgium) and Dice coefficient and UPGMA was 
employed to generate dendrograms. Analysis parameters were set to 2 % for both 
optimization and tolerance values respectively. 
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3.4 Results and Discussion 	  
3.4.1 Susceptibility testing 	  
Prevalence data for resistances in view of the antibiotics tested are summarized in 
Table 1. In total, 16.9% (n=14) of the strains showed resistance to one or more 
antimicrobial agent: 2.4% (n=2) of all E. coli strains were resistant against gentamicin, 
10.8% (n=9) were resistant against kanamycin, 15.7% (n=13) against ampicillin, 
3.6% (n=3) against cephalothin and 1.2% (n=1) against ceftiofur. No resistant strains 
were found for the combination amoxicillin-clavulanic acid. Nine strains (10.8%) were 
resistant against more than one class of antibiotics, the most frequent ones showed 
resistance against kanamycin and ampicillin (7.2%, n=6). One strain (1.2%) showed 
resistance against kanamycin, ampicillin and cephalothin and another strain (1.2%) 
showed resistance against gentamicin, kanamycin and ampicillin. In addition we 
found one ESBL-producer, harbouring blaCTX-M-14, which was also resistant against 
the aminoglycosides kanamycin and gentamicin. The distributions of the inhibition 
zones of all strains are shown in Figure 1. 
A comparison of the results from this study with previous studies in Switzerland 
(Stephan and Rüsch, 1997, Corti et al., 2003) revealed no global changes in the 
resistance situation during the last 15 years. However, concerning cephalothin, 22 
strains fell into the interpretative category "intermediate". This might indicate a shift of 
the population towards resistance and will need to be observed over the next years. 
By comparing the results of this study with recently published data from European 
countries (Hendriksen et al., 2008; Botrel et al., 2010) no obvious differences in view 
of resistance prevalence were evident. 
 
 
3.4.2 Phylogenetic groups 	  
Most of the isolates investigated could be assigned to phylogenetic groups A and B1, 
with 29/83 (34.9%) assigned to group A and 43/83 (51.8%) assigned to group B1. 
Eleven isolates (13.3%) were assigned to the group D and none to phylogenetic 
group B2. With regard to virulence, phylogenetic groups B2 and D are considered to 
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be more likely to carry pathogenicity-associated genes, while groups A and B1 are 
classified commensal strains (Clermont et al., 2000). In our study, most of the 
isolates belonged to groups A and B1. In this context, it is worth mentioning, that this 
was in agreement with findings from a survey showing that E. coli isolates, shed by 
healthy cattle predominantly belonged to lineages A and B1 (Houser et al., 2008). 
However, it cannot be excluded that such strains may harbour some factors which 
may favour e.g. colonization of the udder.  
 
 
3.4.3 Genotyping 	  
The genetic variability was high among the 83 E. coli mastitis isolates from the 67 
farms, and most of the strains were clonally not related based on a cut off value of 
95% (Fig. 2). Even isolates from multiple cows from the same farm displayed diverse 
PFGE patterns. Only three PFGE patterns (two strains each were indistinguishable) 
were found in different farms (Fig. 2). Our data confirm the results of Wenz et al. 
(2006), who also found a high heterogeneity among E. coli strains isolated from cows 
with mastitis. The high genetic heterogeneity among the strains underlines that, in 
contrast to S. aureus (Stutz et al., 2011), no specific E. coli clones are mainly 
responsible for the E. coli mastitis situation.  
This fact further highlights, that besides the use of antibiotics, the strategy for 
treatment of mastitis should be flanked by preventive measures. These comprise a 
number of approaches such as maintenance of a clean, dry, comfortable 
environment; proper milking procedures; proper maintenance and use of milking 
equipment; appropriate management of clinical mastitis during lactation; effective dry 
cow management; maintenance of biosecurity for contagious pathogens and culling 
of chronically infected cows as well as regular monitoring of udder health status. 
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3.7 Tables 	  
Table 1: Antimicrobial agents used in this study, interpretative criteria1 and 
prevalence of resistances (n=83)   
 
 
1according to M31-A3: Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests 
for Bacteria Isolated From Animals; Approved Standard-Third Edition; CLSI, Wayne, USA 2008.  
 
  resistant susceptible resistant strains (%) 
Antimicrobial agents  (inhibition zone 
diameters in mm) 
 
Gentamicin (GM) 10µg ≤12 ≥15 2.4 
Kanamycin (K) 30µg ≤13 ≥18 10.8 
Ampicillin (AM) 10µg  ≤13 ≥17 15.7 
Amoxicillin-clavulanic 
acid (AC) 
20/10µg ≤13 ≥18 0 
Cephalothin (CF) 30µg ≤14 ≥18 3.6 
Ceftiofur (CFT) 30µg ≤17 ≥21 1.2 
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3.8 Figures 	  
Figure 1: Distribution of inhibition zone diameters for the tested antimicrobial agents. 
(GM: gentamicin; K: kanamycin; AM: ampicillin; AC: amoxicillin-clavulanic acid; CF: 
cephalothin; CFT: ceftiofur). 
 
 
 
  
  
  
 
 32 
Figure 2: Cluster analysis and dendrogram of PFGE pattern of 83 E. coli isolates 
from mastitis milk samples. The dendrogram was generated using BioNumerics 
software GelCompare and Dice coefficient and UPGMA. Analysis parameters were 
set to 2 % for both optimization and tolerance values respectively. For clonal 
relationship, the cut off value (see line) was set at 95%. 
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4.1 Abstract 	  
We are describing a clinical case of bovine mastitis due to Arcanobacterium 
pluranimalium in a Holstein-Friesian heifer, delivering bloody milk on the left 
hindquarter. Moreover, we report on the development and evaluation of PCR primers 
based on the pluranimaliumlysin (pla) gene for the identification of this species. With 
the primer pair PlaF/PlaR the A. pluranimalium type strain as well as the mastitis 
isolate 704 revealed a correctly sized amplification product (458 bp), whereas no 
amplification product was obtained for all non-target strains. The established PCR 
provides a new and convenient tool for the mastitis diagnostic to differentiate 
between A. pluranimalium and Trueperella pyogenes.     
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Bovine Mastitis verursacht durch Arcanobacterium pluranimalium und 
Etablierung einer Identifizierungs-PCR basierend auf dem pla Gen 
 
Dieser Bericht beschreibt den Fall einer Holstein-Friesian Färse mit klinischer 
Mastitis (blutige Milch, Hinterviertel links), die durch A. pluranimalium verursacht 
wurde. Zudem wurden im Rahmen dieser Arbeit PCR Primer, basierend auf dem 
Pluranimaliumlysin (pla) Gen, zur Identifizierung von A. pluranimalium evaluiert. 
Sowohl der Referenzstamm wie auch das klinische Isolat 704 zeigten korrekte 
Amplifizierungsprodukte (458bp). Alle nicht-Zielstämme waren in der PCR negativ. 
Die etablierte PCR stellt damit für die Mastitis-Diagnostik ein praktisches Hilfsmittel 
dar, das zur Unterscheidung zwischen A. pluranimalium und Trueperella pyogenes 
herangezogen werden kann. 
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4.2 Case Report 	  
4.2.1 Case history 	  
In May 2012 the diagnostic department of the Institute of Food Safety and Hygiene, 
University of Zurich, received a milk sample from bovine origin. The cow, a Holstein-
Friesian heifer, delivered bloody milk on the left hindquarter since beginning of May 
2012 and decreased milk yield was observed. First, the owner assumed that another 
cow probably hit the cow. He also noticed that this quarter was harder than the other 
three ones. There was no injury, redness or swelling visible. The cow was in a good 
general condition. After 2 weeks without any change in milk appearance, a milk 
sample was aseptically taken and provided for bacteriological analysis. At this time 
the California Mastitis Test (CMT) from this quarter showed a score of 3 (Schalm et 
al., 1971). 
 
 
4.2.2 Diagnostics 	  
The milk was cultured on blood agar and incubated over night at 37°C. The next 
morning there was no visible growth on the plate. After additional 24 hours of 
incubation small (0.5 to 1mm), round, translucent to grey colonies producing a total 
hemolysis were visible (Fig. 1).  
Such colonies showing a total hemolysis on blood agar are typical for Trueperella 
pyogenes (former A. pyogenes; Yassin et al., 2010). Nevertheless, Gram staining of 
these colonies showed no clear picture. MALDI-TOF based identification also yielded 
no result, since there was no match with the available spectra. It was therefore 
decided to further identify these colonies by molecular based methods. The isolate 
(named isolate 704) was investigated by 16S rDNA (primer pair: 616V, 1492R; Loy et 
al., 2002), 23 rDNA (primer pair: 23S-1, 23S-2; Ülbegi-Mohyla et al., 2010) and 16S-
23S rDNA intergenic spacer region (primer pair: c and b; Kostman et al., 1995; 
Chanter et al., 1997; Hassan et al., 2008) sequencing using the amplification 
conditions described in the respective publications. Both, the 948 bp 16S rDNA 
amplicon (GenBank accession number JX144330) as well as the 663 bp 23S rDNA 
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PCR product (JX44331) yielded a 99% identity to the respective sequences of the 
corresponding Arcanobacterium pluranimalium reference strain M430/94/2 (DSM 
13483T). Intergenic spacer region PCR revealed a 534bp sized amplicon (JX144332) 
and a 98% identity to the corresponding A. pluranimalium reference strain sequence.   
The original description of A. pluranimalium is based on an isolate from a harbour 
poroise in Scotland and another from a fallow deer from Sweden (Lawson et al., 
2001). In the years from 2001 to 2009, A. pluranimalium was recovered from 22 
sheep samples as reported by Foster and Hunt (2011) including material from 
abortion, semen, abscesses, viscera and one case each of naval ill and peritonitis. 
Within this study a number of other host species were examined but there was only 
one further isolate of A. pluranimalium which was recovered from a milk sample 
collected from a cow with mastitis. Overall, this suggests that ovine animals are the 
major host of A. pluranimalium, with other host animals rarely affected. 
 
 
4.2.3 Treatment and progress 	  
After collecting a milk sample for the microbiological analysis, the left hindquarter of 
the cow was treated intramammarily with Neo-M (Dr. E. Graeub, Switzerland), which 
contain 1 Mio. U.I. Benzylpenicillinum procainum and 350mg Neomycinum per 10g. 
Four injectors were administered with an interval of 12 hours. A fifth injector was 
administered 24 hours after the fourth one. After the treatment the milk returned to 
normal character and milk yield increased again. Three weeks after milk sampling the 
quarter still showed a hardening but the CMT was negative.  
 
 
 
4.3 Development and evaluation of a pluranimaliumlysin (pla) gene 
based A. pluranimalium specific identification PCR 	  
Until recently the genus Arcanobacterium comprised nine species: A. haemolyticum, 
A. pyogenes, A. bernardiae, A. phocae, A. bialowiezense, A. bonsai, A. hippocoleae, 
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A. abortisuis and A. pluranimalium, many of which were associated with animal hosts 
and/or pyogenic and opportunistic infections (Collins et al., 1982, Lehnen et al., 
2006). In 2010, comparative chemotaxonomic and phylogenetic studies performed by 
Yassin et al. (2010) indicated that the genus Arcanobacterium was not monophyletic 
and it was proposed that the genus Arcanobacterium should be restricted to A. 
haemolyticum, A. hippocolae, A. phocae and A. pluranimalium. The other species A. 
abortisuis, A. bernardiae, A. bialowiezense, A. bonasi and A. pyogenes were 
reclassified in a new genus Trueperella, as Trueperella abortisuis, Trueperella 
bernardiae, Trueperella bialowiezensis, Trueperella bonasi and Trueperella 
pyogenes. 
So far, T. pyogenes and A. pluranimalium have been associated to bovine mastitis. 
Based on colony morphology and the hemolytic activity on blood agar, these two 
species cannot be differentiated from each other. Since no A. pluranimalium specific 
identification PCR had previously been available, a further aim of this study was to 
design and evaluate specific PCR primers for the identification of this species. A 
primer pair (PlaF: 5`- TCG CCA ATC AGA ATC TCG-3` and PlaR: 5`- GTT GTT GAC 
TCC GCG TGC-3`) was designed based on the partial pluranimaliumlysin (pla, 
EMBL_CDS: CBY79009.1) gene sequence of A. pluranimalium type strain 13483T. 
Specificity of the PCR assay was evaluated using the A. pluranimalium type strain as 
a positive control and eight non-target strains (A. haemolyticum DSM 20595T, A. 
hippocoleae DSM 15539T, A. phocae DSM 10002T, Trueperella abortisuis DSM 
19515T, Trueperella bernardiae DSM 9152T, Trueperella bialowiezense DSM 17162T, 
Trueperella bonsai DSM 17163T, Trueperella pyogenes DSM 20630T). 
For amplification, mixtures (total volume 50 µl) containing GoTaq Green Master Mix 
(Promega, Madison, WI) with a final concentration of 1.5 mM MgCl2, 200 µM dNTPs 
each and primers at 10 pmol concentration were prepared. Thermal cycling was 
carried out using an initial denaturation step of 95°C for 2 min, followed by 30 cycles 
of denaturation at 95°C for 30 sec, annealing at 58 °C for 30 sec and elongation at 72 
°C for 30 sec. The amplification product was resolved on a 1 % agarose gel followed 
by ethidium bromide staining and examination under UV light. The PCR assay was 
successfully performed using either (10 ng) of extracted DNA (DNeasy® Blood & 
Tissue Kit, Qiagen, Switzerland) or boiled colony material. 
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With the primer pair PlaF/PlaR the A. pluranimalium type strain as well as isolate 704 
target revealed a correctly sized amplification product (458 bp), whereas no 
amplification product was obtained for all non-target strains (100% specificity). The 
sequenced product of isolate 704 (JX144333) displayed 100% identity to the 
respective sequence of the type strain. The established PCR provides a convenient 
tool for the mastitis diagnostics to differentiate A. pluranimalium from T. pyogenes.   
 
 
 
4.4 Acknowledgements	  	  
We would like to thank Max Wittenbrink for fruitful discussions.  
 
 
 
4.5 References 	  
Chanter N., Collin N., Holmes N., Binns M., Mumford J.: Characterization of the 
Lancefield group C streptococcus 16S-23S RNA gene intergenic spacer and its 
potential for identification and sub-specific typing. Epidemiol. Infect. 1997, 118: 125–
135. 
 
Collins M.D., Jones D., Schofield G.M.: Reclassification of “Corynebacterium 
haemolyticum” (MacLean, Liebow & Rosenberg) in the genus Arcanobacterium gen. 
nov. as Arcanobacterium haemolyticum nom, rev., comb. nov. J. Gen. Microbiol. 
1982, 128: 1279-1281.  
 
Foster G., Hunt B.: Distribution of Arcanobacterium pluranimalium in animals 
examined in veterinary laboratories in the United Kingdom. J. Vet. Diagn. Invest. 
2011, 23: 962-964. 
 
 39 
Hassan A.A., Mohyla H., Kanbar T., Alber J., Lämmler C., Abdulmawjood A., Speck 
S., Zschöck M., Weiss R.: Molecular identification of Arcanobacterium bialowiezense 
and Arcanobacterium bonasi based on 16S–23S rRNA intergenic spacer region 
sequences. Vet. Microbiol. 2008, 130: 410–414. 
 
Kostman J.R., Alden M.B., Mair M., Edlind T.D., LiPuma J.J., Stull T.: A universal 
approach to bacterial molecular epidemiology by polymerase chain reaction 
ribotyping. J. Infect. Dis. 1995, 171: 204-208. 
 
Lawson P.A., Falsen E., Foster G., Eriksson E., Weiss N., Collins M.D.: 
Arcanobacterium pluranimalium sp. nov., isolated from porpoise and deer. Int. J. 
Syst. Evol. Microbiol. 2001, 51: 55-59. 
 
Lehnen A., Busse H.-J., Frölich K., Krasinsky M., Kämpfer P., Speck S.: 
Arcanobacterium bialowiezense sp. nov. and Arcanobacterium bonasi sp. nov., 
isolated from the prepuce of European bison bulls (Bison bonasus) suffering from 
balanoposthitis, and emended description of the genus Arcanobacterium Collins et 
al., 1983. Int. J. Syst. Evol. Microbiol. 2006, 56: 861-866.  
 
Loy A., Küsel K., Lehner A., Drake H.L., Wagner M.: Microarray and functional gene 
analyses of sulfate-reducing prokaryotes in low-sulfate, acidic fens reveal co-
occurrence of recognized genera and novel lineages. Appl. Environ. Microbiol. 2004, 
70: 6998-7009. 
 
Ülbegi-Mohyla H., Hassan A.A., Alber J., Lämmler C., Prenger-Berninghoff E., Weiß 
R., Zschöck M.:  Identification of Arcanobacterium pluranimalium isolated from a dog 
by phenotypic properties and by PCR mediated characterization of various molecular 
targests. Vet. Microbiol. 2010, 142: 458-460. 
 
Schalm O.W., Carroll E. J., Jain N. C.: Physical and Chemical Tests for Detection of 
Mastitis. In: Bovine Mastitis. LEA & FEBIGER, Philadelphia, 1971, 128-157.  
 
Yassin A.F., Hupfer H., Siering C., Schumann P.: Comparative chemotaxonomic and 
phylogenetic studies on the genus Arcanobacterium Collins et al., 1982 emend. 
 40 
Lehnen et al. 2006: proposal for Trueperella gen. nov. and emended description of 
the genus Arcanobacterium. Int. J. Syst. Evol. Microbiol. 2011, 61: 1265-1274. 
 
 
 
4.6 Figures 	  
Figure 1: Small, round, translucent to grey colonies of A. pluranimalium producing 
total hemolysis on blood agar. 
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